Literature DB >> 22202039

Structure and function of the solid tumor niche.

Elisabeth A Pedersen1, Yusuke Shiozawa, Anjali Mishra, Russell S Taichman.   

Abstract

Although the hematopoietic stem cell (HSC) niche has been an active area of study, the concept of the bone marrow microenvironment (BMM) harboring a niche for solid metastatic tumor cells has only recently been considered. The HSC niche and microenvironment that is thought to constitute the solid tumor niche share many of the same structural and functional components, suggesting the possibility that the HSC and tumor niche are one in the same. The osteoblast is a critical component for each of these niches, and is important for regulating cellular processes such homing and migration, growth and survival, and quiescence and dormancy. Current understanding of the HSC niche may provide more insight to better defining the solid tumor niche. As role of the niche in regulating these processes is better understood, new insights to the role of the BMM in metastatic disease may be gained, and provide more potential targets for therapy.

Entities:  

Mesh:

Year:  2012        PMID: 22202039      PMCID: PMC3594847          DOI: 10.2741/s247

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  149 in total

1.  Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells.

Authors:  Jiang Zhu; Russell Garrett; Younghun Jung; Yi Zhang; Nacksung Kim; Jingcheng Wang; Gerard J Joe; Elizabeth Hexner; Yongwon Choi; Russell S Taichman; Stephen G Emerson
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

2.  Expression of the receptor tyrosine kinase Tie2 in neoplastic glial cells is associated with integrin beta1-dependent adhesion to the extracellular matrix.

Authors:  Ok-Hee Lee; Jing Xu; Juan Fueyo; Gregory N Fuller; Kenneth D Aldape; Marta M Alonso; Yuji Piao; Ta-Jen Liu; Frederick F Lang; B Nebiyou Bekele; Candelaria Gomez-Manzano
Journal:  Mol Cancer Res       Date:  2006-12       Impact factor: 5.852

3.  Regulation of the HIF-1alpha level is essential for hematopoietic stem cells.

Authors:  Keiyo Takubo; Nobuhito Goda; Wakako Yamada; Hirono Iriuchishima; Eiji Ikeda; Yoshiaki Kubota; Haruko Shima; Randall S Johnson; Atsushi Hirao; Makoto Suematsu; Toshio Suda
Journal:  Cell Stem Cell       Date:  2010-09-03       Impact factor: 24.633

Review 4.  Solid tumour with initial presentation in the bone marrow--a clinicopathologic study of 25 adult cases.

Authors:  K F Wong; J K Chan; S K Ma
Journal:  Hematol Oncol       Date:  1993 Jan-Feb       Impact factor: 5.271

Review 5.  Models, mechanisms and clinical evidence for cancer dormancy.

Authors:  Julio A Aguirre-Ghiso
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

6.  Osteoblastic cells regulate the haematopoietic stem cell niche.

Authors:  L M Calvi; G B Adams; K W Weibrecht; J M Weber; D P Olson; M C Knight; R P Martin; E Schipani; P Divieti; F R Bringhurst; L A Milner; H M Kronenberg; D T Scadden
Journal:  Nature       Date:  2003-10-23       Impact factor: 49.962

Review 7.  Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells.

Authors:  E Spaeth; A Klopp; J Dembinski; M Andreeff; F Marini
Journal:  Gene Ther       Date:  2008-04-10       Impact factor: 5.250

8.  The role of sialomucin CD164 (MGC-24v or endolyn) in prostate cancer metastasis.

Authors:  A M Havens; Y Jung; Y X Sun; J Wang; R B Shah; H J Bühring; K J Pienta; R S Taichman
Journal:  BMC Cancer       Date:  2006-07-21       Impact factor: 4.430

9.  Hematopoietic stem cells do not depend on N-cadherin to regulate their maintenance.

Authors:  Mark J Kiel; Melih Acar; Glenn L Radice; Sean J Morrison
Journal:  Cell Stem Cell       Date:  2009-02-06       Impact factor: 24.633

10.  CXCR4 is required for the quiescence of primitive hematopoietic cells.

Authors:  Yuchun Nie; Yoon-Chi Han; Yong-Rui Zou
Journal:  J Exp Med       Date:  2008-03-31       Impact factor: 14.307

View more
  4 in total

Review 1.  The prostate cancer bone marrow niche: more than just 'fertile soil'.

Authors:  Elisabeth A Pedersen; Yusuke Shiozawa; Kenneth J Pienta; Russell S Taichman
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

Review 2.  Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.

Authors:  Clara H Lee; Ann M Decker; Frank C Cackowski; Russell S Taichman
Journal:  Cell Biol Toxicol       Date:  2019-06-27       Impact factor: 6.691

3.  AXL Is a Putative Tumor Suppressor and Dormancy Regulator in Prostate Cancer.

Authors:  Haley D Axelrod; Kenneth C Valkenburg; Sarah R Amend; Jessica L Hicks; Princy Parsana; Gonzalo Torga; Angelo M DeMarzo; Kenneth J Pienta
Journal:  Mol Cancer Res       Date:  2018-10-05       Impact factor: 5.852

4.  Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow.

Authors:  Kenji Yumoto; Matthew R Eber; Jingcheng Wang; Frank C Cackowski; Ann M Decker; Eunsohl Lee; Ana Rita Nobre; Julio A Aguirre-Ghiso; Younghun Jung; Russell S Taichman
Journal:  Sci Rep       Date:  2016-11-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.